文献速递免疫规划传染病防控与疫情报告妇幼与学校卫生

2012-2024年全球风疹及先天性风疹综合征消除进展

Progress Toward Rubella and Congenital Rubella Syndrome Elimination - Worldwide, 2012-2024.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2026-07-23

本报告总结2012-2024年全球风疹和先天性风疹综合征(CRS)消除进展。引入含风疹疫苗(RCV)的国家从132/194(68%)增至179(92%),首剂常规RCV全球覆盖率从39%升至73%。报告风疹病例数下降66%(从94,277例降至31,593例),模型估计CRS病例下降约70%,117/194(60%)国家已验证消除地方性风疹病毒传播。

要点

  • 全球RCV引入国家增至179/194(92%),首剂覆盖率升至73%。
  • 风疹报告病例下降66%,CRS模型估计下降约70%。
  • 117/194(60%)国家已验证消除地方性风疹传播。

核心结论

  • 全球风疹和CRS消除取得实质进展,但实现和维持消除仍需所有国家引入RCV并强化免疫与监测体系。

研究设计与样本

  • 基于全球报告数据的描述性分析,汇总2012-2024年各国RCV引入、接种覆盖率、风疹报告病例及CRS模型估计。

主要发现

  • 引入RCV的国家从194个国家中的132个(68%)增至179个(92%)。
  • 首剂常规RCV全球覆盖率从39%升至73%。
  • 风疹报告病例从2012年94,277例降至2024年31,593例,降幅66%。
  • 模型估计同期CRS病例下降约70%。
  • 自2012年加速控制活动开始,194个国家中117个(60%)已验证消除地方性风疹病毒传播。

关键数值与推荐

  • 2024年WHO建议所有国家引入RCV。
  • 单剂RCV提供终身保护。

临床怎么用

  • 预防医学与公共卫生工作者应推动尚未引入RCV的国家引入疫苗,并维持高接种覆盖率。
  • 持续强化风疹和CRS监测系统以验证和维持消除状态。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rubella is the leading cause of vaccine-preventable birth defects. Rubella virus infection during pregnancy can result in miscarriage, fetal death, stillbirth, or a constellation of birth defects known as congenital rubella syndrome (CRS). Vaccination is the primary method for preventing rubella and CRS, and a single dose of rubella-containing vaccine (RCV) provides lifelong protection. In 2024, the World Health Organization recommended introduction of RCV in all countries. Achieving rubella elimination is a priority of the Immunization Agenda 2030. This report summarizes global progress toward elimination of rubella and CRS during 2012-2024. During this period, the number of countries that introduced RCV increased from 132 of 194 (68%) to 179 (92%), and global coverage with the first routinely scheduled dose of RCV rose from 39% to 73%. The number of reported rubella cases declined by 66%, from 94,277 in 2012 to 31,593 in 2024, with large outbreaks increasingly concentrated in fewer countries and geographic shifts observed as vaccine introductions advanced. Modeled estimates suggest that CRS cases declined by approximately 70% during the same period. Since 2012 when accelerated rubella control activities began, 117 of 194 (60%) countries have verified elimination of endemic rubella virus transmission. Despite this, in 2024, approximately 21 million infants aged 12-23 months lived in the 15 countries that had not introduced RCV. Although substantial progress has been made, achieving and sustaining rubella and CRS elimination will require RCV introduction in all the remaining countries and continued commitment from all countries to strengthen immunization and surveillance systems.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Dahlke M, Dautel KA, Vynnycky E, et al. Progress Toward Rubella and Congenital Rubella Syndrome Elimination - Worldwide, 2012-2024. MMWR Morb Mortal Wkly Rep. 2026. PMID: 42490629. doi:10.15585/mmwr.mm7528a1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。